GSK Plans to Reduce Stake in Haleon
05 Outubro 2023 - 1:33PM
Dow Jones News
By Christian Moess Laursen
GSK said its plans to sell 270 million of shares in Haleon,
taking its stake to around 7.4%.
The British pharmaceutical giant said late Thursday that it will
conduct the disposal through a placing of shares in the
consumer-healthcare business.
The offer price will be determined by means of an accelerated
bookbuild offering process which is to start immediately, it
said.
U.S. pharma giant Pfizer holds a 32% stake in Haleon, which was
spun out of GSK and Pfizer's consumer healthcare business.
Write to Christian Moess Laursen at christian.moess@wsj.com
(END) Dow Jones Newswires
October 05, 2023 12:18 ET (16:18 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
GSK (NYSE:GSK)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
GSK (NYSE:GSK)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024
